Dosing regimens for treatment of proliferative disorders
US11813356B2 · kind B2 · utility
0Cited by
6References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 28, 2019 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Jun 5, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes compositions and methods for treating a proliferative disorder comprising administering a therapeutically effective amount of an liposomal curcumin or curcuminoids to a human subject in need thereof in accordance with a dosing regimen comprising: at least one treatment cycle administering the therapeutically effective amount of the liposomal curcumin or curcuminoids once per week of at least 100 mg/m2 over 8 hours.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.